FCMI
Foresite Capital Management I’s 10x Genomics TXG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $21.4M | Hold |
750,000
| – | – | 100% | 1 |
|
|
2022
Q2 | $33.9M | Hold |
750,000
| – | – | 100% | 1 |
|
|
2022
Q1 | $57.1M | Hold |
750,000
| – | – | 99.71% | 1 |
|
|
2021
Q4 | $112M | Hold |
750,000
| – | – | 99.68% | 1 |
|
|
2021
Q3 | $109M | Hold |
750,000
| – | – | 85.42% | 1 |
|
|
2021
Q2 | $147M | Sell |
750,000
-250,000
| -25% | -$49M | 88.53% | 1 |
|
|
2021
Q1 | $181M | Sell |
1,000,000
-250,000
| -20% | -$45.3M | 91.29% | 1 |
|
|
2020
Q4 | $177M | Sell |
1,250,000
-1,500,000
| -55% | -$212M | 93.12% | 1 |
|
|
2020
Q3 | $343M | Sell |
2,750,000
-750,000
| -21% | -$93.5M | 96.54% | 1 |
|
|
2020
Q2 | $313M | Sell |
3,500,000
-2,288,317
| -40% | -$204M | 98.53% | 1 |
|
|
2020
Q1 | $361M | Sell |
5,788,317
-1,447,079
| -20% | -$90.2M | 99.8% | 1 |
|
|
2019
Q4 | $552M | Buy |
+7,235,396
| New | +$552M | 99.92% | 1 |
|